Anti-allergy medicine EpiPen recall expands to US
A recall of the emergency anti-allergy medicine EpiPen is expanding to the U.S. and other markets in North America, Europe, Asia and South America because the allergy shots may not work.
The notice issued Friday by Mylan N.V. expands upon warnings made earlier this month after two reports of the device failing. The recall now covers 13 lots distributed from December 2015 through July 2016.
Mylan didn't immediately respond to a question about how many devices are affected by the recall.
The problems could be potentially life-threatening, although Mylan described the incidence of the defects as "extremely rare."
The EpiPen is used to treat allergic reactions to certain food and bug bites
The products can be replaced at no charge by calling 877-650-3494 or emailing customer.servicemylan.com.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Woman stole nearly $800 in vodka, toilet paper from local Walmart
Thousands in EBR complain about missed trash pick-ups
New Baton Rouge baseball team facing tight stadium renovation deadline
Teachers allege misconduct by McKinley High administrators, demand more oversight
Assumption Parish continues to see rising water